AVITA Medical, Inc.·4

Jun 1, 4:39 PM ET

O'Toole David D 4

4 · AVITA Medical, Inc. · Filed Jun 1, 2026

Research Summary

AI-generated summary of this filing

Updated

AVITA Medical (RCEL) CFO David O'Toole Buys 5,000 Shares via ESPP

What Happened
David D. O'Toole, Chief Financial Officer of AVITA Medical, acquired 5,000 shares of AVITA common stock on May 29, 2026. The shares were purchased under the company's Employee Share Purchase Plan (ESPP) at $3.05 per share for a total reported value of $15,258. This was an acquisition (purchase) rather than a sale.

Key Details

  • Transaction date: 2026-05-29; Price: $3.05 per share; Total value: $15,258.
  • Filing date / accession: Form 4 filed 2026-06-01 (no late-filing flag shown in the provided data).
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnote F1: Shares acquired under the ESPP for the offering period Dec 1, 2025–May 31, 2026; purchase price was 85% of the issuer's closing price on Dec 1, 2025. Transactions were reported as exempt under Rules 16b-3(d) and 16b-3(c).
  • Footnote F2: Reported holdings include unvested restricted stock units (RSUs).

Context
ESPP purchases are routine employee acquisitions made at a discount (here, 85% of the period start closing price) and are treated as exempt compensatory transactions under Rule 16b-3. Such purchases represent insider buying but do not by themselves indicate the insider's future expectations; they reflect participation in the company plan.

Insider Transaction Report

Form 4
Period: 2026-05-29
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-05-29$3.05/sh+5,000$15,258150,927 total
Footnotes (2)
  • [F1]These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2025 and ended on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 1, 2025 (the purchase date of the offering period).
  • [F2]Includes unvested RSUs
Signature
/s/ David O'Toole|2026-06-01

Documents

1 file
  • 4
    ownership.xmlPrimary

    4